| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 3,922,782 | 3,836,329 | 3,441,785 | | Cost of Revenue | 816,680 | 800,114 | 745,602 | | | Gross Profit | 3,106,102 | 3,036,215 | 2,696,183 | | | Operating Expenses | | Research Development | 661,294 | 670,973 | 941,003 | | Selling General and Administrative | 1,474,274 | 1,154,845 | 1,046,336 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 970,534 | 1,210,397 | 708,844 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 970,534 | 1,210,397 | 708,844 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 970,534 | 1,210,397 | 708,844 | | Income Tax Expense | 202,791 | 242,464 | 254,741 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 767,743 | 967,933 | 454,103 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 767,743 | 967,933 | 454,103 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $767,743 | $967,933 | $454,103 |
|
1.48% Nasdaq 
Income Statement
